Rybelsus 3 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FKB81
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,389
Award facts
- Contract value 100% obligated
- $15,389.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Rybelsus 3 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $15,389.47 and an ultimate completion date of September 25, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rybelsus, an oral semaglutide medication for diabetes management, represents part of the company's broader pharmaceutical distribution portfolio supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program is planning to establish next-generation contracts with multiple regional awards, positioning AmerisourceBergen to continue supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FKB81?
SPE2DB25FKB81 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKB81 worth?
The government has obligated $15,389 on SPE2DB25FKB81.
Is contract SPE2DB25FKB81 an order under another contract?
Yes. SPE2DB25FKB81 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKB81 competed?
The extent of competition for SPE2DB25FKB81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award